Presence of Banned Drugs in Dietary Supplements Following FDA Recalls

被引：72

作者：

Cohen, Pieter A. ^{[1
]}

Maller, Gregory ^{[2
]}

DeSouza, Renan ^{[2
]}

Neal-Kababick, James ^{[3
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA USA

[2] Cornell Univ, Ithaca, NY USA

[3] Flora Res Labs, Grants Pass, OR USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 312卷 / 16期

关键词：

D O I：

10.1001/jama.2014.10308

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1691 / 1693

页数：3

共 6 条

[1] Use of a Pharmaceutically Adulterated Dietary Supplement, Pai You Guo, Among Brazilian-Born Women in the United States [J].

Cohen, Pieter A. ;

Benner, Carly ;

McCormick, Danny .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (01) :51-56

[2] The Frequency and Characteristics of Dietary Supplement Recalls in the United States [J].

Harel, Ziv ;

Harel, Shai ;

Wald, Ron ;

Mamdani, Muhammad ;

Bell, Chaim M. .

JAMA INTERNAL MEDICINE, 2013, 173 (10) :926-928

[3] Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-Desisobutyl-11-benzylsibutramine [J].

Mans, Daniel J. ;

Gucinski, Ashley C. ;

Dunn, Jamie D. ;

Gryniewicz-Ruzicka, Connie M. ;

Mecker-Pogue, Laura C. ;

Kao, Jeff L. -F. ;

Ge, Xia .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 83 :122-128

[4]

U.S. FDA, SAF REC MARK WITHDR

[5]

U.S. Food and Drug Administration, TAINT SUPPL CDER

[6]

US Food and Drug Administration, REC HLTH FRAUD

← 1 →